Cargando…

Diffuse hepatic and splenic Tc-99m MDP tracer uptake in case of multiple myeloma

Tc-99m methylene diphosphonate (MDP) bone scintigraphy has long been used for the evaluation of benign as well as malignant skeletal conditions. However, non-osseous tracer uptake on a bone scan is an unusual finding. There is a need to understand the pathophysiological basis of the non-osseous upta...

Descripción completa

Detalles Bibliográficos
Autores principales: Sood, Ashwani, Seam, Rajeev Kumar, Sethi, Sandeep, Gupta, Manish
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3003289/
https://www.ncbi.nlm.nih.gov/pubmed/21188069
http://dx.doi.org/10.4103/0972-3919.72692
Descripción
Sumario:Tc-99m methylene diphosphonate (MDP) bone scintigraphy has long been used for the evaluation of benign as well as malignant skeletal conditions. However, non-osseous tracer uptake on a bone scan is an unusual finding. There is a need to understand the pathophysiological basis of the non-osseous uptake, which may have a clinical relevance or deteriorating effect on the quality of the bone scan. We describe a case of multiple myeloma, where extraosseous uptake in the form of diffuse hepatic and splenic uptake, with almost normal skeletal tracer distribution, has been seen on the bone scan.